DC Pharma

Zuienkerke ·KBO/BCE: BE 0727.644.411

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	30-07-2025	1 d early	2025-00347738
31-12-2023	31-07-2024	29-08-2024	29 d late	2024-00402863
31-12-2022	31-07-2023	26-06-2023	35 d early	2023-00155582
31-12-2021	31-07-2022	08-06-2022	53 d early	2022-20057291
31-12-2020	31-07-2021	30-06-2021	31 d early	2021-30200280
31-12-2019	31-07-2020	30-06-2020	31 d early	2020-26000414

Metric	This company	Sector median	Position in the sector
Solvency	42.4%	53.8%	better than 40% of 3174 sector peers
Net result	€70k	€18k	better than 86% of 3173 sector peers
Equity	€543k	€40k	better than 95% of 3176 sector peers
Gross operating margin	€102k	€36k	better than 83% of 3173 sector peers
Total assets	€1.28M	€93k	better than 95% of 3179 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€1.28M
Fixed assets	21/28	€1.19M
Tangible fixed assets	22/27	€38k
Financial fixed assets	28	€1.15M
Current assets	29/58	€93k
Amounts receivable within one year	40/41	€58k
Cash & bank	54/58	€35k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€1.28M
Equity	10/15	€543k
Contributions / capital	10/11	€13k
Reserves	13	€531k
Amounts payable	17/49	€738k
Amounts payable after one year	17	€640k
Amounts payable within one year	42/48	€98k
Trade debts payable within one year	44	€1k
Income statement
Gross operating margin	9900	€102k
Operating result	9901	€99k
Financial charges	65	€11k
Result before taxes	9903	€88k
Income taxes	67/77	€18k
Net result for the period	9904	€70k
Result to be appropriated	9905	€70k

Summary